IOSCO

Incentives to centrally clear over-the-counter (OTC) derivatives

A post-implementation evaluation of the effects of the G20 financial regulatory reforms.

Evaluation of incentives to centrally clear OTC derivatives: Overview of responses to the consultation

An overview of responses to the August 2018.

FSB and standard-setting bodies publish final report on effects of reforms on incentives to centrally clear over-the-counter derivatives

Standard-setters publish final report on evaluation of the effects of the G20 reforms on incentives to centrally clear OTC derivatives.

Report on Retail OTC Leveraged Products

The guidance identifies and promotes regulatory approaches that can enhance the protection of retail investors in the area of OTC leveraged products offered and sold to retail investors.

Conflicts of interest and associated conduct risks during the equity capital raising process

Guidance to address the identified risks and the potential harm caused by specific, existing conflicts of interest and associated misconduct which can arise during the equity capital raising process.

Public responses to the consultation on Incentives to centrally clear over-the-counter (OTC) derivatives

Consultation responses to 'Incentives to centrally clear over-the-counter (OTC) derivatives'.

Study highlights continued central clearing interdependencies

CCP resources and central clearing exposures are concentrated at a small number of financial institutions.

Analysis of Central Clearing Interdependencies

A study by standard-setters on the interdependencies between CCPs and clearing members and other financial service providers.

Incentives to centrally clear over-the-counter (OTC) derivatives

Consultative document on the effects of the G20 financial regulatory reforms on incentives to centrally clear OTC derivatives.

FSB and standard-setting bodies consult on effects of reforms on incentives to centrally clear over-the-counter derivatives

Standard-setters consult on evaluation of the effects of the G20 reforms on incentives to centrally clear OTC derivatives.

Archives

2023 (10)
2022 (6)
August (1)
July (2)
April (1)
March (2)
2020 (3)
2017 (11)
2016 (3)
August (1)
June (1)
May (1)
2014 (3)
July (1)
2013 (9)
August (1)
July (2)
June (1)
May (1)
March (1)
2012 (12)
2011 (4)
May (1)
2010 (5)
August (1)
July (1)
May (1)
April (1)
2009 (6)
July (1)
June (3)
May (1)
2008 (2)
July (1)
May (1)
2007 (2)
2006 (2)
August (1)
March (1)
2004 (1)
May (1)
2002 (3)
2001 (1)
April (1)
2000 (1)